SCHEMBL6493937

SCHEMBL6493937

O=C(Nc1ccc(-c2cnco2)cc1)C(=O)Nc1cccc(CN(C(=O)O)c2ccccc2)c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 7/20 0.52
NPC1 O15118 4/20 0.51
RAB9A P51151 3/20 0.51
KDM4E B2RXH2 3/20 0.51
PKM P14618 2/20 0.51
ALDH1A1 P00352 2/20 0.51
LMNA P02545 1/20 0.51
IMPDH1 P20839 1/20 0.49
PORCN Q9H237 1/20 0.47
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
AAK1 Q2M2I8 2/20 0.42
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
PDK1 Q15118 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.40
JAK3 P52333 1/20 0.40
CASR P41180 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6485457 0.83 IMPDH2 (0.56) IMPDH2NPC1RAB9AKDM4EPKM
SCHEMBL6499362 0.81 IMPDH2 (0.59) IMPDH2NPC1RAB9AKDM4EPKM
Trifluoroacetic Acid SCHEMBL27561206 0.77 IMPDH2 (0.53) IMPDH2NPC1RAB9AKDM4EPKM
SCHEMBL6486557 0.77 IMPDH2 (0.54) IMPDH2NPC1RAB9AKDM4EPKM
SCHEMBL14027190 0.73 KMT2A (0.76) IMPDH2NPC1RAB9AKDM4EPKM
SCHEMBL27542606 0.73 IMPDH2 (0.64) IMPDH2NPC1RAB9AKDM4EPKM
SCHEMBL6484655 0.73 IMPDH2 (0.64) IMPDH2NPC1RAB9AKDM4EPKM
SCHEMBL6500618 0.72 IMPDH2 (0.72) IMPDH2IMPDH1AAK1
SCHEMBL7552277 0.71 IMPDH2 (0.60) IMPDH2NPC1RAB9AKDM4EPKM
SCHEMBL12749611 0.71 NPC1 (0.65) IMPDH2NPC1RAB9AKDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6867299-B2 Inosine monophosphate dehydrogenase (IMPDH); use as immunosuppressants, anticancer agents and antiviral agents HOFFMANN-LA ROCHE INC. (US) 2005-03-15 US disclosed